Sarcomas are a heterogeneous group of rare cancers of mesenchymal origin. Bone tissue sarcoma is a cancer that occurs in bones and muscles. It is a tumor that develops in bone tissues. This tumor can occur randomly in any bone inside the body. Patients with bone cancer could experience bone pain, swelling, fatigue, and weight loss. The most common sarcomas include osteosarcoma and chondrosarcoma.
Most frequently diagnosed form of primary bone cancer is Ewing sarcoma, which mostly occurs in children and young adults. The disease can occur at any stage of an individual, but it is very uncommon in people over 30 years of age.
Sarcomas can be treated by various methods, including surgery, radiation, and chemotherapy. Currently, targeted therapies, in which only the damaged cells are targeted and normal cells are not affected, are in trend.
Therefore, research related to bone tissue sarcoma treatment is at its peak
In terms of region, the global bone tissue sarcoma market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
In North America, the pandemic has significantly affected the US, which has led to disruptions in surgical procedures. Currently, precautionary measures are taken during surgical procedures, which would lead to steady market expansion.
North America currently captures a major share of the bone tissue sarcoma treatment market, and is expected to continue it for the next few years. A number of clinical trials are underway for bone cancer therapies, especially in the U.S., which is expected to increase its market share in the near future. New chemo drugs are currently in the trial phase. Researchers are looking for new ways to improve the approved drug portfolio. Experts are studying whether the addition of bisphosphonates such as zoledronic acid to bone cement could reduce the chances of tumor recurrence.
In Europe, methotrexate has been accepted as a standard agent. Apart from methotrexate, mifanurtide has been approved for the treatment of patients undergoing osteosarcoma.
The global bone tissue sarcoma market is highly concentrated due to presence of key players. A large number of manufacturers hold major shares in their respective regions. Demand for bone tissue sarcoma treatment has increased in emerging as well as developed markets due to rise in awareness about technologically advanced products. Growth strategies adopted by leading players are likely to drive the global market. Major players operating in the global bone tissue sarcoma treatment market are listed below:
Global Bone Tissue Sarcoma Treatment Market, by Type
Global Bone Tissue Sarcoma Treatment Market, by Treatment Type
Global Bone Tissue Sarcoma Treatment Market, by End-user
Global Bone Tissue Sarcoma Treatment Market, by Region
Interested in this report?
Get a FREE Brochure now!
*Get Brochure (PDF) sent to your email within minutes
Complete the form below and we'll get back to you shortly.